drugset / Trial / NCT03497715
Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.
RandomizedCrossoverOpen-labelTreatment
Summary
The study will be an adaptive, 2 part, single dose, 5-way crossover gamma scintigraphy study in healthy subjects, to investigate the rate and site of tablet disintegration of various forms of Ibuprofen.
Timeline
- Start
- 2015-04-14
- Primary completion
- 2015-07-30
- Completion
- 2015-07-30
Outcome
Outcome not reported
Stopped: “On completion of part 1 it was felt that there would be no benefit in completing part 2”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | 400 mg | Oral |
| Subject | Ibuprofen | Small molecule | 512 mg | Oral |
| Subject | Ibuprofen | Small molecule | 684 mg | Oral |
Indications
No indication recorded.